In oncology care, clinical success is defined primarily by time: months or years of survival. Yet for patients living with ...

What began as a convenience play has evolved into something more consequential: a shift in where trust is built; how ...

Marketing-centric engagement, designed for lower-complexity markets where scale and awareness are priorities. This model ...

A major shift in approach is needed if patient-reported adverse events are to enable clearer safety insights and better ...

Looking across late-stage pharma R&D, three dominant themes emerge for 2026. These reflect a maturing AI landscape, ...

Whether they are navigating a tough media grilling as a crisis unfolds or translating a complex research breakthrough for a ...

Gene therapies delivered major breakthroughs, including treatments that halve cholesterol levels in patients with inherited cardiovascular risk, advances for people living with thalassemia and highly ...

Ahmed Moussa has been appointed as the new Sanofi Country Lead for the UK & Ireland, taking over from Rippon Ubhi. In his new ...

Despite all their talk of more strategic exploitation of data over the last ten to 15 years, the life sciences remain ...

ALK has announced that its EURneffy 1mg nasal adrenaline spray has received a positive opinion from the Committee for ...

NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, has announced the appointment of Thomas J Farrell as ...

Kahimmune Therapeutics, a biotechnology company specialising in immuno-oncology, has entered an exclusive licensing agreement with Gustave Roussy and Société d’Accélération du Transfert de ...